New “First” Program: Six Months of Free Lab Space for Eligible First-Time Biotech Founders >
Apply for Residency
Apply for Residency
Apply for Residency
Apply for Residency
Apply for Residency

Search

LabCentral 2018 Impact Report: Resident Companies Raised the Equivalent of 40% of Early Life Sciences VC Funding in Massachusetts and 6% of U.S. Life Sciences IPOs

Kendall Square launchpad for high-potential life…

Bristol Myers-Squibb LabCentral 'Golden Ticket' Submission

LabCentral Appoints Biotech Industry Luminary Dr. Susan Windham-Bannister to its Board of Directors

SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors

Novo Nordisk to award promising start-ups free space at Boston's premier, biotech-capable shared lab facility

Pfizer Inc. Awards “Golden Tickets” to Neutrolis and Mediar Therapeutics

Read More

Astellas Commits Nearly $13 Million to Fund Boston-area Start-Up Innovation in Cell and Gene Therapy

Read More

Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases

Quench Bio emerges with $50M to treat severe inflammatory diseases

Rgenta Therapeutics Recipient of Servier's 2020 LabCentral Golden Ticket